<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[EPIX Pharmaceuticals Inc. | Company News & Executive Profiles - EPIX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/epix+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for EPIX Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Epix Surrenders Battle to Keep Alzheimer's Program Afloat]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F167303-epix-surrenders-battle-to-keep-alzheimer-s-program-afloat%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Even as they were announcing their FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patients, EPIX Pharmaceuticals, Inc. (OTC:EPIX) plans quietly to wind down operations after a hard fought battle to keep the company afloat. The Lexington, Mass.-based company&#8217;s officials said...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 19 Oct 2009 07:26:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/epix+pharmaceuticals+inc..html"><![CDATA[EPIX Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPIX</category>
		<category domain="tickers">EPIX</category>
	</item>
	<item>
		<title><![CDATA[EPIX Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-236680.html]]></link>
		<description><![CDATA[ Earnings Call ExcerptEPIX Pharmaceuticals Inc. EPIX Q2 2008 Earnings Call August 7, 2008 10:00 am ET Executives  Elkan Gamzu - Interim Chief Executive Officer Kimberlee Cobleigh Drapkin - Chief Financial Officer Analysts  Mike Yee - RBC Capital Markets Alan Carr - Needham & Co Jon Lecroy -...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 23 Sep 2008 19:58:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/epix+pharmaceuticals+inc..html"><![CDATA[EPIX Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPIX</category>
		<category domain="tickers">EPIX</category>
	</item>
	<item>
		<title><![CDATA[EPIX Pharmaceuticals Secures Committed Equity Financing Facility]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_5/ai_n27969183]]></link>
		<description><![CDATA[Financing Facility May Provide Up To $50 Million of Capital  LEXINGTON, Mass. -- EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, announced today that it has entered into a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 05 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/epix+pharmaceuticals+inc..html"><![CDATA[EPIX Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[financing]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/warrant.html"><![CDATA[warrant]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPIX</category>
		<category domain="tickers">EPIX</category>
	</item>
	<item>
		<title><![CDATA[EPIX Pharmaceuticals Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229745.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Thank you. Operator Instructions And your first question comes from the line of Ted Tenthoff with Piper Jaffray. Ted Tenthoff - Piper Jaffray Great. Thank you very much. Can you hear me at here Michael? Michael Kauffman We can. Ted Tenthoff - Piper Jaffray Great. How...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 25 Feb 2008 14:57:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/epix+pharmaceuticals+inc..html"><![CDATA[EPIX Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EPIX</category>
		<category domain="tickers">EPIX</category>
	</item>
</channel>
</rss>
